AstraZeneca receives fresh blow to potassium drug

FILE PHOTO: The logo of AstraZeneca is seen on a medication package at a pharmacy in London April 28, 2014. REUTERS/Stefan Wermuth/File Photo AstraZeneca said on Friday that U.S. regulators had rejected the British company’s new drug for high potassium levels,... More »